Vascular plaque formation

"Vascular plaque formation" is not a specific molecule, receptor, or canonical therapeutic target. Instead, it refers to the pathological process by which plaques—composed of lipids (mainly cholesterol), inflammatory cells (such as macrophages and T-cells), smooth muscle cells, and connective tissue—accumulate within the walls of arteries. This process is central to the development of atherosclerosis, which underlies most cardiovascular diseases including heart attacks and strokes[1][3][5]. The molecular mechanisms involve multiple cell types and signaling pathways rather than a single druggable entity. Key steps include endothelial dysfunction, retention and modification of low-density lipoprotein (LDL) particles in the vessel wall, recruitment of immune cells via adhesion molecules (e.g., VCAM-1, ICAM-1), foam cell formation through scavenger receptors like LOX-1 and CD36 on macrophages, smooth muscle proliferation, extracellular matrix remodeling, calcification, necrosis/apoptosis within plaques leading to instability or rupture[1][2]. While individual molecules involved in these processes can be considered therapeutic targets (e.g., LOX-1 receptor for oxidized LDL uptake[2]), "vascular plaque formation" itself is too broad and non-specific to serve as a canonical molecular target. Summary: "Vascular plaque formation" describes a complex biological process rather than an individual molecule or receptor; therefore it does not fit standard definitions for structured drug target information[1][2][3][5].

Other names

Atherosclerotic plaque formationPlaque buildupVascular atheroma development